The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Structural Heart Devices Global Market Report 2023, the structural heart devices market is expected to show promising growth in the forecast period.

Market Overview

• Current Market Size: The structural heart devices market has demonstrated significant growth, increasing from $9.5 billion in 2023 to $10.4 billion in 2024. This growth represents a compound annual growth rate (CAGR) of 9.5%.
• Future Projections: The market is expected to expand to $15.06 billion by 2028, with a CAGR of 9.7%.

Drivers of Growth

• Minimally Invasive Techniques: The shift towards less invasive surgical methods and the demand for minimally invasive structural heart devices are key growth factors.
• Healthcare Expenditure: Rising healthcare spending and increasing patient preference for non-surgical treatment options have contributed to market expansion.
• Training and Education: Ongoing training programs for healthcare professionals have enhanced the adoption of structural heart devices.

Growth Factors for the Forecast Period

• Aging Population: An increasing aging population is driving demand for structural heart devices.
• Awareness and Screening: Growing awareness about heart health and the implementation of screening programs are contributing to market growth.
• Reimbursement Policies: Favorable reimbursement policies and timely regulatory approvals for new devices support market expansion.

View More On The Structural Heart Devices Market Report 2024 –
https://www.thebusinessresearchcompany.com/report/structural-heart-devices-global-market-report

Key Trends

• Transcatheter Valve Replacement: There is a rising adoption of transcatheter valve replacement technologies.
• Innovative Devices: The development of new devices with advanced materials is on the rise.
• Personalized Treatment: A growing emphasis on personalized treatment approaches is shaping the market.
• Hybrid Procedures: Increasing use of hybrid procedures is becoming more prevalent.
• Remote Monitoring and Telehealth: Integration of remote monitoring and telehealth solutions is gaining traction.

Impact of Cardiovascular Diseases

• Prevalence of CVDs: The rising prevalence of cardiovascular diseases (CVDs) is a significant driver for the structural heart devices market.
• Global Statistics: According to the American Heart Association, cardiovascular diseases caused 931,578 deaths in the US in January 2024. Globally, CVD deaths increased from 19.05 million in 2020 to 19.91 million in 2021.
• Device Applications: Structural heart devices are used to repair or replace damaged heart valves and improve heart function.

Technological Advancements

• Minimally Invasive Devices: Companies are developing advanced minimally invasive devices to enhance patient outcomes and reduce recovery times.
• Case Study: Abbott Laboratories launched the Navitor transcatheter aortic valve implantation (TAVI) system in December 2022. This self-expanding system is designed to improve hemodynamics and provide better access to coronary arteries for future interventions.

Strategic Acquisitions

• Genesis MedTech and JC Medical: In February 2022, Genesis MedTech Group acquired JC Medical, adding the J-Valve transcatheter aortic valve replacement device to its portfolio. This acquisition enhances Genesis MedTech’s offerings in structural heart devices.

Market Segmentation

• By Type: Includes heart valve devices, annuloplasty rings, occluders, and delivery systems.
• By Procedure: Comprises replacement procedures and repair procedures.
• By Indication: Covers atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and other indications.
• By Age Group: Segmented into pediatric and adult populations.

Regional Insights

• North America: Was the largest market in 2023, driven by advanced healthcare infrastructure.
• Asia-Pacific: Expected to be the fastest-growing region in the forecast period due to increasing healthcare investments and rising demand for structural heart devices.

Conclusion

The structural heart devices market is poised for substantial growth, fueled by advancements in minimally invasive technologies, an aging population, and increasing prevalence of cardiovascular diseases. With ongoing innovations and strategic acquisitions, the market is set to expand further, providing improved treatment options and outcomes for patients with structural heart conditions.

Request A Sample Of The Global Structural Heart Devices Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15677&type=smp